FORT WORTH, Texas, -- June 26, 2025—Omnicell, Inc. (Nasdaq: OMCL) (“Omnicell” or the “Company”), a leader in transforming the pharmacy and nursing care delivery model, today announced that OmniSphere, the Company’s next-generation, cloud native, software workflow engine and data platform, has successfully received HITRUST CSF (Common Security Framework) i1 certification.
The HITRUST CSF i1 certification for OmniSphere complements Omnicell’s existing HITRUST i1 certification for its suite of medication management solutions – an attestation that these products are managing risk to a high industry standard through key information security controls and cybersecurity practices.
The new HITRUST certification for OmniSphere reinforces Omnicell’s commitment to achieving high standards in data protection. The certification scope for OmniSphere includes Omnicell’s cloud platform in Amazon Web Services and all Omnicell solutions that leverage the platform, including the company’s Inventory Optimization Service, Essentials, and Omnicell Telemetry Services including Central Pharmacy Dispensing Service, IVX Analytics, and Command Center. Together, the HITRUST i1 certifications for both OmniSphere and Omnicell’s medication management solutions reflect Omnicell’s position as a leader in end-to-end medication management security.
The certification scope covers our Cloud platform in Amazon Web Services (AWS), so it includes all components in AWS – Inventory Optimization Services, Essentials (CDP and EDP), Omnicell Telemetry Services including CPDS, IVX Analytics, and Command Center.
“In an industry where cybersecurity attacks pose a near constant threat to providers and patients, we believe it is imperative for Omnicell to ensure its medication management solutions and the cloud platform that supports them achieves the highest data protection standards,” said Giri Chodavarapu, Senior Vice President and Chief Information Officer at Omnicell. “Our HITRUST CSF i1 Certification for OmniSphere demonstrates that our cloud platform adheres to the stringent standards and requirements of one of the most trusted security assessment leaders in the healthcare sector.”
“The HITRUST i1 Validated Assessment is a powerful tool for cyber-aware organizations, such as Omnicell,” said Robert Booker, Chief Strategy Officer at HITRUST. “HITRUST i1 Certification provides measurement, implementation, and performance assurance of information security controls. Congratulations to Omnicell for earning HITRUST i1 Certification and demonstrating the operational maturity of their cybersecurity program.”
About Omnicell
Since 1992, Omnicell has been committed to transforming the pharmacy care delivery model in an effort to optimize financial and clinical outcomes across all settings of care. Through a comprehensive portfolio of automation and advanced services, Omnicell is uniquely positioned to address evolving healthcare challenges, connect settings of care, and streamline the medication management process. Healthcare facilities worldwide partner with Omnicell to help increase operational efficiency, reduce medication errors, improve patient safety, and enhance patient engagement and adherence, helping to reduce costly hospital readmissions. To learn more, visit omnicell.com.
From time to time, Omnicell may use the Company’s investor relations website and other online social media channels, including its LinkedIn page www.linkedin.com/company/omnicell, and Facebook page www.facebook.com/omnicellinc, to disclose material non-public information and comply with its disclosure obligations under Regulation Fair Disclosure (“Reg FD”).
OMNICELL and the Omnicell logo are registered trademarks of Omnicell, Inc. or one of its subsidiaries.
Forward-Looking Statements
To the extent any statements contained in this press release deal with information that is not historical, these statements are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Without limiting the foregoing, statements including the words “expect,” “intend,” “may,” “will,” “should,” “would,” “could,” “plan,” “potential,” “anticipate,” “believe,” “forecast,” “guidance,” “outlook,” “goals,” “target,” “estimate,” “seek,” “predict,” “project,” and similar expressions are intended to identify forward-looking statements. Forward-looking statements are subject to the occurrence of many events outside Omnicell’s control. Such statements include, but are not limited to, the benefits of HITRUST CSF (Common Security Framework) i1 Certification, Omnicell’s management of risk to a high industry standard through key information security controls and cybersecurity practices, and Omnicell’s medication management solutions and OmniSphere cloud platform’s ability to achieve the highest data protection standards and adhere to the stringent cybersecurity standards and requirements. Actual results and other events may differ significantly from those contemplated by forward-looking statements due to numerous factors that involve substantial known and unknown risks and uncertainties. These risks and uncertainties include, among other things, (i) risks presented by government regulations, legislative changes, fraud and anti-kickback statues, products liability claims, the outcome of legal proceedings, and other legal obligations related to healthcare, privacy, data protection, and information security, and the costs of compliance with, and potential liability associated with, our actual or perceived failure to comply with such obligations, including any potential governmental investigations and enforcement actions, litigation, fines and penalties, exposure to indemnification obligations or other liabilities, and adverse publicity related to the same, (ii) any disruption in Omnicell’s information technology systems and breaches of data security or cyber-attacks on its systems or solutions, including the previously disclosed ransomware incident and any potential adverse legal, reputational, and financial effects that may result from it and/or additional cybersecurity incidents, as well as the effectiveness of business continuity plans during any future cybersecurity incidents (iii) Omnicell’s dependence on a limited number of suppliers for certain components, equipment, and raw materials, as well as technologies provided by third-party vendors, and (iv) other risks and uncertainties further described in the “Risk Factors” section of Omnicell’s most recent Annual Report on Form 10-K, as well as in Omnicell’s other reports filed with or furnished to the United States Securities and Exchange Commission (“SEC”), available at www.sec.gov. Forward-looking statements should be considered in light of these risks and uncertainties. Investors and others are cautioned not to place undue reliance on forward-looking statements. All forward-looking statements contained in this press release speak only as of the date of this press release. Omnicell assumes no obligation to update any such statements publicly, or to update the reasons actual results could differ materially from those expressed or implied in any forward-looking statements, whether as a result of changed circumstances, new information, future events, or otherwise, except as required by law.